Xenograft tumor models revealed discernible tumor growth inhibition in cells with diminished SEC14L3 expression, as evidenced by reduced tumor volumes and weights compared to those in the NC group (Fig. 2g-i). The gene discussed is SEC14L3; the disease is neoplasm.